Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag in Treatment-naive Severe Aplastic Anemia
CTR20190158Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetrombopag in aplastic anemia, sponsored by Hengrui Therapeutics. Started Feb 2019; status: completed.
02
Drugs
hetrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on CTR20190158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190158.